Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07075341 · ClinicalTrials.gov registry record

Healthy Living BEYOND Weight Study

A clinical trial of Overweight or Obesity, sponsored by American Heart Association.

Recruiting
Registry status
1,000,000
Enrollment target
1
Study location

NCT07075341: Recruiting study of Overweight or Obesity, sponsored by American Heart Association.

NCT07075341 is a study of Overweight or Obesity that is actively recruiting participants, run by American Heart Association. The registered enrollment target is 1,000,000 participants, above the 463-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (215883% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07075341, a study of Overweight or Obesity, is actively recruiting participants, sponsored by American Heart Association.

RECRUITING
Registry status
1,000,000 participants
Enrollment target
1
Study location

Study Summary

The Healthy Living BEYOND Weight Study is an observational research study of participants living with overweight and obesity. The principal objectives for this project will be to answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity, and to assess the real-world effectiveness of different weight management strategies, within contemporary and diverse populations. To accomplish this, the Study Team for this project will leverage their expertise in the science of obesity and cardiometabolic health; epidemiology, cohort and registry studies; implementation science; cardiovascular prevention and management; and disparities and community-based research to lead the development of an innovative cohort of people living with overweight or obesity with two key components: 1. patient-report data elements, obtained through surveys; 2. linkage to EHR records providing data regarding clinical encounters. The cohort will be inclusive, comprehensive, and constructed with scientific rigor as well as high internal and external validity. An overall objective is for the Healthy Living BEYOND Weight Study is to serve as an enduring resource for researchers studying the health consequences of obesity and evaluating the impact of weight management strategies.

Conditions Studied

Overweight or Obesity

Interventions

  • OTHER None - Observational study

Study Locations (1)

Texas

  • American Heart Association - Dallas

Trial Details

FieldValue
Enrollment Target 1,000,000 participants
Start Date 2025-06-30
Est. Completion 2060-12
American Heart Association

9 total trials

What NCT07075341 shows while recruiting

NCT07075341 is an observational study that tracks outcomes without assigning an intervention. Its 1,000,000 participants enrollment target places it among the larger protocols in the corpus, above the 463-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (215883% higher).

The record links to 1 condition, with Overweight or Obesity appearing as the primary indexed condition, and to 1 intervention - of which None - Observational study is the first listed.

NCT07075341 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07075341 about?

NCT07075341 is a clinical study titled "Healthy Living BEYOND Weight Study". The Healthy Living BEYOND Weight Study is an observational research study of participants living with overweight and obesity. The principal objectives for this project will be to answer fundamental unanswered questions regarding patient experiences and outcomes related to overweight and obesity, and...

What is the current status of trial NCT07075341?

This trial is currently recruiting. The enrollment target is 1,000,000 participants. The study started on 2025-06-30. Estimated completion is 2060-12.

What conditions does trial NCT07075341 study?

This clinical trial studies the following conditions: Overweight or Obesity.

What interventions are being tested in trial NCT07075341?

The interventions under investigation include: None - Observational study (OTHER).

Who is sponsoring clinical trial NCT07075341?

This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07075341 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overweight or Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07075341's enrollment target sits among peer trials

1,000,000 1st of 32 higher than 32 of 32 other Overweight or Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight or Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05066763 · 1,000,000 participants

    Parkinson's Foundation Surveys

  • NCT07224685 · 1,000,000 participants

    A Study of Mayo Clinic CV Research Heart & Voice Study

  • NCT06029933 · 960,000 participants

    Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

  • NCT01073475 · 950,000 participants

    Maternal Newborn Health Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07075341

Source: ClinicalTrials.gov NCT07075341, the US trial registry maintained by the National Library of Medicine. NCT07075341 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.